<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Simone Tzaridis | Pfau Lab</title>
    <link>https://pfaulab.com/author/simone-tzaridis/</link>
      <atom:link href="https://pfaulab.com/author/simone-tzaridis/index.xml" rel="self" type="application/rss+xml" />
    <description>Simone Tzaridis</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© {2022} Maximilian Pfau</copyright><lastBuildDate>Wed, 01 Feb 2023 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://pfaulab.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png</url>
      <title>Simone Tzaridis</title>
      <link>https://pfaulab.com/author/simone-tzaridis/</link>
    </image>
    
    <item>
      <title>Tamoxifen retinopathy and macular telangiectasia type 2: Similarities and differences on multimodal retinal imaging</title>
      <link>https://pfaulab.com/publication/hess-2023-bs/</link>
      <pubDate>Wed, 01 Feb 2023 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/hess-2023-bs/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Morphological characteristics preceding exudative neovascularisation secondary to macular telangiectasia type 2</title>
      <link>https://pfaulab.com/publication/hess-2022-vg/</link>
      <pubDate>Thu, 01 Dec 2022 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/hess-2022-vg/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Hyperreflectivity on optical coherence tomography in macular telangiectasia Type 2</title>
      <link>https://pfaulab.com/publication/tzaridis-2021-oo/</link>
      <pubDate>Thu, 01 Jul 2021 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/tzaridis-2021-oo/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2</title>
      <link>https://pfaulab.com/publication/tzaridis-2021-dh/</link>
      <pubDate>Sat, 01 May 2021 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/tzaridis-2021-dh/</guid>
      <description></description>
    </item>
    
    <item>
      <title>WITHDRAWN: Hyper-reflectivity on optical coherence tomography in macular telangiectasia type 2</title>
      <link>https://pfaulab.com/publication/tzaridis-2020-yj/</link>
      <pubDate>Sun, 01 Nov 2020 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/tzaridis-2020-yj/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dark adaptation in macular telangiectasia Type 2</title>
      <link>https://pfaulab.com/publication/tzaridis-2020-jv/</link>
      <pubDate>Thu, 01 Oct 2020 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/tzaridis-2020-jv/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dark-adapted two-color fundus-controlled perimetry in macular telangiectasia type 2</title>
      <link>https://pfaulab.com/publication/heeren-2019-rd/</link>
      <pubDate>Mon, 01 Apr 2019 00:00:00 +0000</pubDate>
      <guid>https://pfaulab.com/publication/heeren-2019-rd/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
